At Sequentify, we empower genomic labs to achieve scalable, population-wide genomic sequencing through our innovative solutions. Our technology is designed to decentralize genomic testing by addressing the industry's top three challenges: sample preparation, result analysis, and cost reduction. Our end-to-end solution offers unmatched scalability, automation friendliness, and cost-effectiveness, making it ideal for diverse applications, including cancer diagnostics, carrier screening, and infectious disease. Currently raising our Series A round, as we aim to accelerate growth.
| Website | http://www.sequentify.com |
| Employees | 7 (3 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology |
| Keywords | Genomic Sequencing, Next Generation Sequencing, Genomic Testing, Genome Sequencing, Sequencing Technology, Ngs, High Throughput Sequencing, Dna Sequencing, Genomic Data Analysis, Genetic Testing, Sample Preparation, Clinical Genomics, Bioinformatics, Precision Medicine, Laboratory Automation, Dna Analysis, Healthcare It |
| Competitors | Microsoft, Zapier, Workato, Make, n8n, Parabola, Tray.io, Pipedream, IFTTT, Automate.io (acquired by Notion) +48 more (view full list) |
Looking for a particular Sequentify employee's phone or email?
Tom Fleischer is the Co-founder and CEO of Sequentify.
3 people are employed at Sequentify.
Sequentify is based in Rehovot, Center District.